plerixafor has been researched along with Bone Loss, Osteoclastic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hatano-Sato, K; Hosomichi, J; Ishida, Y; Li, K; Mahatumarat, K; Ongprakobkul, N; Ono, T; Petdachai, S; Usumi-Fujita, R | 1 |
| Chen, A; Cheng, P; Dong, Y; Guo, F; Huang, H; Liu, H; Qin, L; Xu, F; Yang, Q; Zhang, X | 1 |
| Apicelli, A; Eagleton, MC; Hirbe, AC; Morgan, EA; Piwnica-Worms, D; Prior, JL; Trinkaus, K; Uluçkan, O; Weilbaecher, K | 1 |
3 other study(ies) available for plerixafor and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Effects of local vs systemic administration of CXCR4 inhibitor AMD3100 on orthodontic tooth movement in rats.
Topics: Animals; Benzylamines; Bone Resorption; Cathepsin K; Core Binding Factor Alpha 1 Subunit; Cyclams; Osteoclasts; Rats; Receptors, CXCR4; Tooth Movement Techniques; X-Ray Microtomography | 2022 |
Inhibition of SDF-1α/CXCR4 Signalling in Subchondral Bone Attenuates Post-Traumatic Osteoarthritis.
Topics: Animals; Benzylamines; Biomarkers; Bone and Bones; Bone Remodeling; Bone Resorption; Cartilage, Articular; Cell Differentiation; Chemokine CXCL12; Cyclams; Disease Models, Animal; Gene Expression; Heterocyclic Compounds; Male; Mice; Osteoarthritis; Osteoclasts; Receptors, CXCR4; Signal Transduction; Wounds and Injuries; X-Ray Microtomography | 2016 |
Granulocyte colony-stimulating factor enhances bone tumor growth in mice in an osteoclast-dependent manner.
Topics: Animals; Anti-HIV Agents; Benzylamines; Bone Density; Bone Neoplasms; Bone Resorption; Cell Movement; Cyclams; Granulocyte Colony-Stimulating Factor; Heterocyclic Compounds; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Neutropenia; Neutrophils; Osteoclasts; Receptors, CXCR4; Tumor Burden | 2007 |